|
3D QSAR STUDIES ON A SERIES OF QUINAZOLINE DERRIVATIVES AS TYROSINE
KINASE (EGFR) INHIBITOR: THE k-NEAREST NEIGHBOR MOLECULAR FIELD ANALYSIS APPROACH
Malleshappa N. Noolvi* and Harun M. Patel
Department of Pharmaceutical Chemistry, ASBASJSM College of
Pharmacy, Bela (Ropar)-14011, Punjab, India
|
Date of Web Publication
|
15-Aug-2010
|
Corresponding Author*: E-mail: mnoolvi@yahoo.co.uk
ABSTRACT
|
|
|
Epidermal growth factor receptor (EGFR) protein tyrosine kinases (PTKs) are known
for its role in cancer. Quinazoline have been reported to be the molecules of interest,
with potent anticancer activity and they act by binding to ATP site of protein kinases.
ATP binding site of protein kinases provides an extensive opportunity to design
newer analogs. With this background, we report an attempt to discern the structural
and physicochemical requirements for inhibition of EGFR tyrosine kinase. The k-Nearest
Neighbor Molecular Field Analysis (kNN-MFA), a three dimensional quantitative structure
activity relationship (3D- QSAR) method has been used in the present case to study
the correlation between the molecular properties and the tyrosine kinase (EGFR)
inhibitory activities on a series of quinazoline derivatives. kNN-MFA calculations
for both electrostatic and steric field were carried out. The master grid maps derived
from the best model has been used to display the contribution of electrostatic potential
and steric field. The statistical results showed significant correlation coefficient
r2 (q2) of 0.846, r2 for external test set (pred_r2)
0.8029, coefficient of correlation of predicted data set (pred_r2se)
of 0.6658, degree of freedom 89 and k nearest neighbor of 2.Therefore, this study
not only casts light on binding mechanism between EGFR and its inhibitors, but also
provides hints for the design of new EGFR inhibitors with observable structural
diversity.
KEYWORDS: Quinazoline, Tyrosine kinase (EGFR), k-Nearest Neighbor Molecular Field
Analysis (kNN-MFA).
INTRODUCTION
|
|
|
Many of the tyrosine kinase enzymes are involved in cellular signaling pathways
and regulate key cell functions such as proliferation, differentiation, anti-apoptotic
signaling and neurite outgrowth. Unregulated activation of these enzymes, through
mechanisms such as point mutations or over expression, can lead to a large percentage
of clinical cancers [1, 2].The importance of tyrosine kinase enzymes in
health and disease is further underscored by the existence of aberrations in tyrosine
kinase enzymes signaling occurring in inflammatory diseases and diabetes. Inhibitors
of tyrosine kinase as a new kind of effective anticancer drug are important mediators
of cellular signal transduction that affects growth factors and oncogenes on cell
proliferation [3, 4]. The development of tyrosine kinase inhibitors has therefore
become an active area of research in pharmaceutical science. Epidermal growth factor
receptor (EGFR) which plays a vital role as a regulator of cell growth is one of
the intensely studied tyrosine kinase targets of inhibitors. EGFR is overexpressed
in numerous tumors, including those derived from brain, lung, bladder, colon, breast,
head and neck. EGFR hyper activation has also been implicated in other diseases
including polycystic kidney disease, psoriasis and asthma [5–7]. Since
the hyper activation of EGFR has been associated with these diseases, inhibitor
of EGFR has potential therapeutic value and it has been extensively studied in the
pharmaceutical industry.
One could not, however, confirm that the compounds designed would always possess
good inhibitory activity to EGFR, while experimental assessments of inhibitory activity
of these compounds are time-consuming and expensive. Consequently, it is of interest
to develop a prediction method for biological activities before the synthesis. Quantitative
structure activity relationship (QSAR) searches information relating chemical structure
to biological and other activities by developing a QSAR model. Using such an approach
one could predict the activities of newly designed compounds before a decision is
being made whether these compounds should be really synthesized and tested.
Many different approaches to QSAR have been developed over the years. The rapid
increase in three-dimensional structural information (3D) of bioorganic molecules,
coupled with the development of fast methods for 3D structure alignment (e.g. active
analogue approach), has led to the development of 3D structural descriptors and
associated 3D QSAR methods. The most popular 3D QSAR methods are comparative molecular
field analysis (CoMFA)and comparative molecular similarity analysis (CoMSIA) [8, 9].The
CoMFA method involves generation of a common three dimensional lattice around a
set of molecules and calculation of the steric and electrostatic interaction energies
at the lattice points. The interaction energies are numerically very high when a
lattice point is very close to an atom and special care needs to be taken in order
to avoid problems arising because of this. The CoMSIA method avoids these problems
by using similarity function represented as Gaussian. This information around the
molecule is converted into numerical data using the partial least squares (PLS)
method that reduces the dimensionality of data by generating components. However,
a major disadvantage is that PLS attempts to fit a linear curve among all the points
in the data set. Further, the PLS method does not offer scope for improvement in
results. It has been observed from several reports that the predictive ability of
PLS method is rather poor due to fitting of a linear curve between the available
points. In the case of the CoMSIA method, molecular similarity is evaluated and
used instead of molecular field, followed by PLS analysis.
Variable selection methods have also been adopted for optimal region selection in
3D QSAR methods and shown to provide improved QSAR models as compared to the original
CoMFA technique. For example, GOLPE was developed using chemometric principles,
and q2-GRS was developed on the basis of independent analyses of small areas (or
regions) of near molecular space to address the issue of optimal region selection
in CoMFA [10, 11]. These considerations provide an impetus for the development
of fast, generally nonlinear, variable selection methods for performing molecular
field analysis. With the above facts and in continuation of our research for newer
anti-cancer agent [12, 13] in the present study, we report here the development
of a new method (kNNMFA) that adopts a k-nearest neighbor principle for generating
relationships of molecular fields with the experimentally reported activity to provide
further insight into the key structural features required to design potential drug
candidates of this class. This method utilizes the active analogue principle that
lies at the foundation of medicinal chemistry.
COMPUTATIONAL
METHODS
|
|
|
A. Methodology
We hereby report the models, as generated by kNN-MFA in conjunction with stepwise
(SW) forward-backward variable selection methods. In the kNN-MFA method, several
models were generated for the selected members of training and test sets, and the
corresponding best models are reported herein. VLife Molecular Design Suite (VLifeMDS),
allows user to choose probe, grid size, and grid interval for the generation of
descriptors. The variable selection methods along with the corresponding parameters
are allowed to be chosen, and optimum models are generated by maximizing q2. k-nearest
neighbor molecular field analysis (kNN-MFA) requires suitable alignment of given
set of molecules. This is followed by generation of a common rectangular grid around
the molecules. The steric and electrostatic interaction energies are computed at
the lattice points of the grid using a methyl probe of charge +1. These interaction
energy values are considered for relationship generation and utilized as descriptors
to decide nearness between molecules. The term descriptor is utilized in the following
discussion to indicate field values at the lattice points. The optimal training
and test sets were generated using the sphere exclusion algorithm [14]. This algorithm allows the construction of
training sets covering descriptor space occupied by representative points. Once
the training and test sets were generated, kNN methodology was applied to the descriptors
generated over the grid.
1. Nearest Neighbor (kNN) Method
The kNN methodology relies on a simple distance learning approach whereby an unknown
member is classified according to the majority of its k-nearest neighbors in the
training set. The nearness is measured by an appropriate distance metric (e.g.,
a molecular similarity measure calculated using field interactions of molecular
structures). The standard kNN method is implemented simply as follows: Calculate
distances between an unknown object (u) and all the objects in the training set;
select k objects from the training set most similar to object u, according to the
calculated distances; and classify object u with the group to which the majority
of the k objects belongs. An optimal k value is selected by optimization through
the classification of a test set of samples or by leave-one out cross-validation
[15].
2. kNN-MFA with Simulated Annealing
Simulated annealing (SA) is the simulation of a physical process, ‘annealing’,
which involves heating the system to a high temperature and then gradually cooling
it down to a preset temperature (e.g., room temperature). During this process, the
system samples possible configurations distributed according to the Boltzmann distribution
so that at equilibrium, low energy states are the most populated.
3. kNN-MFA with Stepwise (SW) Variable Selection
This method employs a stepwise variable selection procedure combined with kNN to
optimize the number of nearest neighbors (k) and the selection of variables from
the original pool as described in simulated annealing.
4. kNN-MFA with Genetic Algorithm
Genetic algorithms (GA) first described by Holland [16]
mimic natural evolution and selection. In biological systems, genetic information
that determines the individuality of an organism is stored in chromosomes. Chromosomes
are replicated and passed onto the next generation with selection criteria depending
on fitness.
B] Chemical Data
One hundred twenty six quinazoline derivatives as tyrosine kinase (EGFR) inhibitors
were taken from the literature and used for kNN-MFA analysis [17-28]. The above
reported quinazoline derivatives showed wide variation in their structure and potency
profiles. kNN-MFA (3DQSAR) models were generated for these derivatives using a training
set of 98 molecules. Predictive power of the resulting models was evaluated by a
test set of 28 molecules with uniformly distributed biological activities. Selection
of test set molecules was made by considering the fact that test set molecules represent
structural features similar to compounds in the training set [29]. The structures of all compounds along with their actual
and predicted biological activities are shown in Table 1(A-Y).
C] BIOLOGICAL ACTIVITIES
126 quinazoline derivatives having different substitution were divided into two
sets, 98 (75%) molecules were taken for the training set and 28 (25%) compounds
were taken in for the test set. IC50 (μM) values for EGFR inhibition were
transformed into –log (IC50* 10-6) i.e. pIC50 [30]. Since some compounds exhibited insignificant/no inhibition,
such compounds were excluded from the present study. All the IC50 values had been
obtained using the in vitro MTT assay method [31,
32]. The IC50 values of reference compounds
were checked to ensure that no difference occurred between different groups. The
pIC50 values of the molecules under study spanned a wide range from 5 to 9.
D] Data Set
All computational work was performed on Apple workstation (8-chore processor) using
Vlife MDS QSAR plus software developed by Vlife Sciences Technologies Pvt Ltd, Pune,
India, on windows XP operating system. All the compounds were drawn in Chem DBS
using fragment database and then subjected to energy minimization using batch energy
minimization method.
E] Molecular Modeling and Alignment
Conformational search were carried out by systemic conformational search method
and lowest energy conformers were selected. All the compounds were aligned by template
based method. The selection of template molecule for alignment was done by considering
the following facts: a) the most active compound; b) the lead or commercial compound;
c) the compound containing the greatest number of functional group [33,34
].Generally, the low energy conformer of the most active compound is selected as
a reference [35].In the present study,
all the compounds were aligned against minimum energy conformation of most active
compound no.28 (Figure1) by using quinazoline nucleus
as template shown Figure 2.
F] Selection of Training and Test Set
The dataset of 126 molecules was divided into training and test set by Sphere Exclusion
(SE) method for model 1, model 2 and model 3 having dissimilarities values of 8.2,8.3
and 8.1 respectively with pIC50 activity field as dependent variable
and various 3D descriptors calculated for the compounds as independent variables.
G] Cross-Validation Using Weighted K-Nearest Neighbor.
This is done to test the internal stability and predictive ability of the QSAR models.
Developed QSAR models were validated by the following procedure:
a) Internal Validation.
(1) A molecule in the training set was eliminated, and its biological activity was
predicted as the weighted average activity of the k most similar molecules (eq.
1). The similarities were evaluated as the inverse of Euclidean distances between
molecules (eq. 2) using only the subset of descriptors corresponding to the current
trial solution
k–Nearest neighbor
(2) Step 1 was repeated until every molecule in the training set has been eliminated
and its activity predicted once.
(3) The cross-validated r2 (q2) value was calculated
using eq. 3, where yi and ŷ are the actual and predicted activities
of the ith molecule, respectively, and ymean is the average k-Nearest
neighbor activity of all molecules in the training set. Both summations are over
all molecules in the training set. Since the calculation of the pairwise molecular
similarities, and hence the predictions, were based upon the current trial solution,
the q2 obtained is indicative of the predictive power of the current kNN-MFA
model.
b) External Validation.
The predicted r2 (pred_r2) value was calculated using eq 4, where yi
and yˆi are the actual and predicted activities of the ith
molecule in test set, respectively, and ymean is the average activity of
all molecules in the training set. Both summations are over all molecules in the
test set. Thepred_r2 value is indicative of the predictive power of the current
kNN-MFA model for external test set.
Both summations are over all molecules in the test set. Thus, the pred_r2
value is indicative of the predictive power of the current model for external test
set.
c) Randomization Test.
To evaluate the statistical significance of the QSAR model for an actual data set,
we have employed a one-tail hypothesis testing [36-37]. The robustness of the QSAR models
for experimental training sets was examined by comparing these models to those derived
for random data sets. Random sets were generated by rearranging biological activities
of the training set molecules. The significance of the models hence obtained was
derived based on calculated Z score [36-37].
Where h is the q2 value calculated for the actual dataset,
µ the average q2, and σ is its standard deviation calculated
for various iterations using models build by different random datasets.The probability
(α) of significance of randomization test is derived by comparing Z score
value with Z score critical value, if Z score value is less than 4.0; otherwise
it is calculated by the formula as given in the literature. For example, a Z score
value greater than 3.10 indicates that there is a probability (α) of less
than 0.001 that the QSAR model constructed for the real dataset is random. The randomization
test suggests that all the developed models have a probability of less than 1% that
the model is generated by chance.
EXPERIMENTAL
|
|
|
All the one hundred twenty six compounds were built on workstation of molecular
modeling software VlifeMDS, which is a product Vlife Sciences Pvt Ltd., India [38]. We hereby report the models,
as generated by kNN-MFA in conjunction with stepwise (SW) forward-backward variable
selection methods shown in Table 2.
In the present kNN-MFA study, (-13.2343 to19.1320) × (-12.0268 to15.04940)
× (-11.2513 to15.4959) A0grid at the interval of 2.00 was
generated around the aligned compounds. The steric and electrostatic interaction
energies are computed at the lattice points of the grid using a methyl probe of
charge +1 of Gasteiger-Marsili type. These interaction energy values are considered
for relationship generation and utilized as descriptors to decide nearness between
molecules.The QSAR models were developed using forward-backward variable selection
method with pIC50activity field as dependent variable and physico-chemical
descriptors as independent variable having cross-correlation limit of 1, 0.8 and
0.9 for mode 1, model 2 and model 3 respectively. Selection of test and training
set was done by sphere exclusion method having dissimilarity value of 8.2, 8.3 and
8.1 for mode 1, model 2 and model 3 respectively. Variance cut off point was 0.0.
Numbers of maximum and minimum neighbors were 5 and 2 respectively.
The method described above has been implemented in software, Vlife Molecular Design
Suite (VlifeMDS), [38] which allows
user to choose probe, grid size, and grid interval for the generation of descriptors.
The variable selection methods along with the corresponding parameters are allowed
to be chosen, and optimum models are generated by maximizing q2.
Steps Involved In kNN-MFA Method
1. Molecules are optimized before alignment optimization is done by MOPAC energy
minimization and optimization is necessary process for proper alignment of molecules
around template.
2. kNN-MFA method requires suitable alignment of given set of molecules, alignment
are template based.
3. This is followed by generation of common rectangular grid around the molecules,
the steric and electrostatic interaction energies are computed at the lattice points
of the grid using a methyl probe of charge +1.
4.The optimal training and test set were generated using sphere exclusion method.
5. Model was generated by various kNN methods, and models validated internally and
externally by leave one out, external validation.
6. Predict the activity of test set of compounds.
Since the final equations are not very useful to represent efficiently the kNN-MFA
models, 3D master grid maps of the best models are displayed. They represent area
in space where steric and electrostatic field interactions are responsible for the
observed variation of the biological activity.
RESULTS
AND DISCUSSION
|
|
|
Training set of 98 and test set of 28 quinazoline derivatives having different substitution
were employed. Following statistical measure was used to correlate biological activity
and molecular descriptors: n = number of molecules, Vn= number of descriptors, k
= number of nearest neighbor, df =degree of freedom, r2 = coefficient
of determination, q2 = cross validated r2(by the leave-one
out method), pred_r2 = r2 for external test set, pred_r2se
= coefficient of correlation of predicted data set, Z score = the Z score calculated
by q2 in the randomization test, best_ran_q2 = the highest q2 value in the randomization
test and α = the statistical significance parameter obtained by the randomization
test.
Selecting training and test set by spherical exclusion method, Unicolumn statics
shows that the max of the test is less than max of train set and the min of the
test set is greater than of train set shown in Table 3,
which is prerequisite analysis for further QSAR study. The above result shows that
the test is interpolative i.e. derived within the min-max range of the train set.
The mean and standard deviation of the train and test provides insight to the relative
difference of mean and point density distribution of the two sets. In this case
the mean in the test set higher than the train set shows the presence of relatively
more active molecules as compared to the inactive ones. Also the similar standard
deviation in both set indicates that the spread in both the set with their respective
mean is comparable.
The activity distribution graph shows the comparison between the activity of training
and test set. It can be observed from Hierarchical Graph that the test set molecule
activities lie within the range of training set, shown in Figure
3.
The observed and predicted pIC50 along with residual values for model
1 are shown in Table 1(A-W). The plot of observed vs.
predicted activity is shown in Figure 4 From the plot
it can be seen that kNN-MFA model is able to predict the activity of training set
quite well (all points are close to regression line) as well as external.
During the kNN-MFA investigation, dissimilarity value for the selection of training
and test by spherical exclusion method of range 8.0000 to 9.5000 were investigated.
The dissimilarity value of 8.200 produced a significant result as compare to the
8.100 and 8.300 shown in Table 2. Further increase in
resolution have produced decrease in model quality. From the Table
2 it was observed that the results were less sensitive to resolution of
dissimilarity value.
It is known that the CoMFA method provides significant value in terms of a new molecule
design, when contours of the PLS coefficients are visualized for the set of molecules.
Similarly, the kNN-MFA models provide direction for the design of new molecules
in a rather convenient way. The points which contribute to the kNN-MFA models 1
is displayed in Figure 5. The range of property values
for the chosen points may aid in the design of new potent molecules (Figure
5). The range is based on the variation of the field values at the chosen
points using the most active molecule and its nearest neighbor set.
The q2, pred_r2, Vn and k value of kNN-MFA with model 1, 2 and 3 were (0.8463, 0.8029,
06/2) (0.7487, 0.7192, 05/2) and (0.7802, 0.7412, 06/2) respectively. Among these
three methods, model 1 have better q2 (0.8463) and pred_r2 (0.8029) than other two
models, model 1correctly predicts activity 84.63% and 80.29% for the training and
test set respectively. It uses 1 steric and 5 electronic descriptors with 2 k nearest
neighbor to evaluate activity of new molecule.
The model is validated by α_ran_q2 = 0.0001, best_ran_q2
= 0.03060, and Z score_ran_q2 = 15.25775.The randomization test suggests
that the developed model have a probability of less than 1% that the model is generated
by chance.
The kNN MFA models obtained by using all the three dissimilarity values showed that
electrostatic and steric interactions plays major role in determining biological
activity.S_1462 in model 1, S_1462,S_2892, S_734 in model 2 and S_1099, S_1631,
S_512 in model 3 are steric field descriptors similarly E_1882, E_2289, E_2287,
E_2615, E_2874 in model 1, E_1515, E_1882 in model 2,and E_2289, E_1911, E_2272
model 3 are electrostatic field descriptors. It can also be noted that electrostatic
descriptor E_1882 and steric descriptor S_1462 was common in the Model 1 and Model
2 using forward-backward variable selection method implying the significant role
of these descriptors in electrostatic and steric field interaction for the structure
activity relationship.
Negative value in electrostatic field descriptors indicates that negative electronic
potential is required to increase activity and more electronegative substituents
group is preferred in that position, positive range indicates that group that imparting
positive electrostatic potential is favorable for activity so less electronegative
group is preferred in that region. Similarly negative range in steric descriptors
indicates that negative steric potential is favorable for activity and less bulky
substituents group is preferred in that region, Positive value of steric descriptors
reveals that positive steric potential is favorable for increase in activity and
more bulky group is preferred in that region.
n, number of observations (molecules); Vn, number of descriptors; k, number of nearest
neighbors; q2,cross-validated r2 (by the leave-one out method); pred_r2, predicted
r2 for the external test set; Zscore, the Zscore calculated by q2 in the randomization
test; best_ran_q2, the highest q2 value in the randomization test and α _ran_q2,
the statistical significance parameter obtained by the randomization test.
CONCLUSION
|
|
|
In conclusion, the model developed to predict the structural features of quinazoline
to inhibit EGFR tyrosine kinase, reveals useful information about the structural
features requirement for the molecule. In all three optimized models, Model 1 is
giving very significant results. The master grid obtained for the various kNN-MFA
models show that negative value in electrostatic field descriptors indicates the
negative electronic potential is required to increase activity and more electronegative
substituents group is preferred in that position, positive range indicates that
the group which imparts positive electrostatic potential is favorable for activity
so less electronegative group is preferred in that region. Negative range in steric
descriptors indicates that negative steric potential is favorable for activity and
less bulky substituents group is preferred in that region, Positive value of steric
descriptors reveals that positive steric potential is favorable for increase in
activity and more bulky group is preferred in that region. On the basis of the spatial
arrangement of the various shapes, electrostatic and steric potential contributions
model proposed in this work is useful in describing QSAR of quinazoline derivatives
as EGFR tyrosine kinase inhibitor and can be employed to design new derivatives
of quinazoline with specific inhibitory activity.
ACKNOWLEDGEMENTS
|
|
|
The authors would like to thank Director General, Department of Science and Technology,
New Delhi for funding the project (Grant.No.SR/FT/LS-0083/2008) and Sardar Sangat
Singh Longia, Secretary ASBASJSM College of Pharmacy for providing the necessary
facilities.
REFERENCES
|
|
|
|
|
|
1.
|
Kurup R, Garg C and Hansch. Chem. Rev. 2001; 101: 2573–2600.
|
|
2.
|
Palmer BD, Krake AJ, Hartl BG, et al. J. Med. Chem. 1999; 42: 2373–2382.3.
|
|
3.
|
Oblak M, Randic M and Solmajer T. J. Chem. Inf. Comput. Sci. 2000; 40: 994–1001.
|
|
4.
|
Naumann T and Matter T. J. Med. Chem. 2002; 45: 2366–2378.
|
|
5.
|
Bridges AJ, Zhou H, Cody DR, et al. J. Med. Chem. 1996; 39: 267–276.
|
|
6.
|
Ma KA, Bower H, Lin G, et al. Biochem. Pharmacol. 2005:69:1785–1794.
|
|
7.
|
Albuschat R, Lowe W, Weber M, et al. Eur. J. Med. Chem. 2004; 39: 1001–1011.
|
|
8.
|
Cramer RD, Patterson DE and Bunce JD. J. Am. Chem. Soc. 1988;110: 5959.
|
|
9.
|
Klebe G, Abraham U and Mietzner T. J. Med. Chem. 1994; 37: 24.
|
|
10.
|
Baroni M, Costantino G, Cruciani G, et al. An Advanced Chemometric Tool for Handling
3D-QSAR Problems. Quant. Struct.-Act. Relat. 1993; 12: 9.
|
|
11.
|
Cho SJ and Tropsha A. J. Med. Chem. 1995; 38: 1060.
|
|
12.
|
Manjula SN, Noolvi MN, Parihar KV, et al. Synthesis and anti-tumour activity of
optically active thiourea and their 2-aminobenzothiazole derivatives: A novel class
of anticancer agents. Eur. J. Med. Chem. 2009: 1–7.
|
|
13.
|
Badiger AM, Noolvi MN and Nayak PV. QSAR study of Benzthiazole derivatives as p56
lck inhibitors. Lett. Drug. Des. Discov. 2006; 3:550–560.
|
|
14.
|
Golbraikh A and Tropsha A. J. Chem. Inf. Comput. Sci. 2003; 43: 144.
|
|
15.
|
Sharaf MA, Illman DL and Kowalski BR. Chemometrics.Wiley, New York, 1986.
|
|
16.
|
Holland, J. Adaptation in Natural and Artificial Systems, University of Michigan
Press, 1975.
|
|
17.
|
KitanoY, Suzuki T, Kawahara E, et al. Synthesis and inhibitory activity of 4-alkenylquinazolines:
Identification of new scaffolds for potent EGFR tyrosine kinase inhibitors. Bioorg.
Med. Chem. Lett. 2007; 17: 5863–5867.
|
|
18.
|
Chandregowda V, Kush AK and Reddy C. Synthesis and in vitro antitumour activities
of novel 4 – Anilinoquinazolines derivatives. Eur. J. Med. Chem. 2009; 44:
3046–3055.
|
|
19.
|
Mishani E, Abourbeh G, Rozen Y, et al. Novel carbon -11 labeled 4-dimethylamino
but-2-enoic acid [4 –(phenylamino) –quinazoline–6–yl]
–amides:potential PET bioprobes for molecular imaging of EFGR positive tumours.
Nucl. Med. Biol. 2004; 31: 469–476.
|
|
20.
|
Dissoki S, Aviv Y, Laky D, et al. The effect of the [18F] - PEG group
on tracer qualification of [4-(phenylamino) - quinazoline-6-yl] -amide moiety -
an EGFR putative irreversible inhibitor. Int. J. Appl. Radiat. Isot. 2007; 65: 1140–1151.
|
|
21.
|
Abouzid K and Shouman S. Design, synthesis and in vitro anti-tumour activity of
4-aminoquinoline and 4-aminoquinazoline derivatives targeting EGFR tyrosine kinase.
Bioorg. Med. Chem. 2008; 16: 7543–7551.
|
|
22.
|
Shaul M, Abourbeh G, Jacobson O, et al. Novel iodine -124 labeled EGFR inhibitors
as potential PET agents for molecular maging in cancer. Bioorg. Med. Chem. 2004;
12: 3421–3429.
|
|
23.
|
Gibson KH, Grundy W, Godfrey AA, et al. Epidermal growth factor receptor tyrosine
kinase: Structure activity relationship and anti-tumour activity of novel quinazoline.
Bioorg. Med. Chem. Lett. 1997; 7: 2723–2728.
|
|
24.
|
Zhang Y, Cockrill S, Guntrip S, et al. Synthesis and SAR of potent EGFR / erB2 dual
inhibitors. Bioorg. Med. Chem. Lett.,2004, 14: 111–114.
|
|
25.
|
Liu L, Yuan T, Liu H, et al. Synthesis and biological evaluation of substituted
6-alkynyl – 4 – Anilinoquinazolines derivatives as potent EGFR inhibitors.
Bioorg. Med. Chem. Lett. 2007, 17; 63:73–6377.
|
|
26.
|
Bridges A, Cody D, Zhou H, et al.Enantioselective inhibition of the epidermal growth
factor receptor tyrosine kinase by 4-( - phenethylamino) quinazolines. Bioorg. Med.
Chem. 1995; 3: 1651–1656.
|
|
27.
|
Lowe W and Luth AEJ. Synthesis of 4- ( indole -3-yl) quinazolines - A new class
off epidermal growth factor receptor tyrosine kinase inhibitors.Eur. J. Med. Chem.
2008; 43: 1478–1488.
|
|
28.
|
Rachid Z, MacPhee M, Williams C, et al. Design and synthesis of new stabilized combi-triazenes
for targeting solid tumours expressing the epidermal growth fator receptor (EGFR)
or its closest homologue HER2. Bioorg. Med. Chem. Lett. 2009, article in press.
|
|
29.
|
Murthy VS and Kulkarni VM. 3D-QSAR CoMFA and CoMSIA on Protein Tyrosine Phosphatase
1B Inhibitors. Bioorg. Med. Chem. 2002; 10: 2267–2282.
|
|
30.
|
Sachan N, Kadam SS and Kulkarni VM. Human Protein Tyrosine Phosphatase 1B Inhibitors:
QSAR by Genetic Function Approximation. J. Enzyme Inhib. Med. Chem. 2007; 22: 267–276.
|
|
31.
|
Rusnak DW, Lackey K, Affleck K, et al. Mol. Cancer. Ther. 2001; 1:85.
|
|
32.
|
Skehan P, Storeng R, Scudiero D, et al. J. Natl. Cancer. Inst.1990; 82:1107.
|
|
33.
|
Agarwal A and Taylor EW. 3-D QSAR for intrinsic activity of 5-HT1a receptor
ligands by the method of comparative molecular field analysis. J. Computat. Chem.1993;
14: 237–245.
|
|
34.
|
Baurin N, Vangrevelinghe E and Allory LM. 3D-QSAR CoMFA study on imidazolinergic
i2 ligands: a significant model through a combined exploration of structural
diversity and methodology. J. Med. Chem. 2000; 43: 1109–1122.
|
|
35.
|
Xu M, Zhang A, Han S and Wang L. Studies of 3D-Quantitative Structure-Activity Relationships
on a set of nitroaromatic compounds: CoMFA advanced CoMFA and CoMSIA. Chemosphere.
2002; 48: 707–715.
|
|
36.
|
Zheng W and Tropsha A. J. Chem. Inf. Comput. Sci. 2000; 40: 185.
|
|
37.
|
Gilbert N, Statistics, Saunders WB Co, Philadelphia, PA. 1976.
|
|
38.
|
VLifeMDS2.0, Molecular Design Suite, Vlife Sciences Technologies Pvt. Ltd., Pune,
India, 2004, (www.vlifesciences.com).
|

























|